Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Aug 22, 2013 ryan arthur f Director Disposition (Non Open Market) 4,042 236.64
May 1, 2013 mccorkle douglas s Officer Automatic Sell 3,662 233.53
May 1, 2013 schleifer leonard s Officer Automatic Sell 100,000 225.01 - 250.06
Apr 12, 2013 mccorkle douglas s Officer Automatic Sell 3,129 205.82 - 214.10
Apr 11, 2013 mccorkle douglas s Officer Automatic Sell 2,746 204.57
Jan 9, 2013 goldstein joseph l Director Automatic Sell 5,000 185.00
Nov 29, 2012 sing george l Director Sell 5,000 185.00
Dec 11, 2012 aberman michael s Officer Automatic Sell 3,368 184.85 - 185.18
Dec 10, 2012 aberman michael s Officer Automatic Sell 4,132 182.68
Nov 29, 2012 aberman michael s Officer Automatic Sell 4,430 182.20
Nov 30, 2012 stahl neil Officer Sell 17,182 181.01
Jan 3, 2013 powchik peter Officer Automatic Sell 13,586 180.83 - 183.10
Jan 4, 2013 goldstein joseph l Director Automatic Sell 5,000 180.50 - 181.22
Nov 30, 2012 aberman michael s Officer Automatic Sell 3,904 180.08 - 184.00
Apr 1, 2013 goldstein joseph l Director Automatic Sell 5,000 180.00
Dec 14, 2012 goldberg murray a Officer Automatic Sell 4,607 179.13
Dec 14, 2012 stahl neil Officer Automatic Sell 8,386 179.13
Dec 14, 2012 yancopoulos george Officer Automatic Sell 38,391 179.13
Dec 17, 2012 yancopoulos george Officer Automatic Sell 238,535 179.13
Dec 18, 2012 powchik peter Officer Automatic Sell 21,269 178.62
Showing 121-140 of 790 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)